News
And Full Year Gross Profit And Gross Margin Improved Year Over Year; Double Digit EPS Growth for Fourth Quarter Fourth Quarter Fiscal ...
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company ...
1 Day BNED -4.55% DJIA -1.91% Russell 2K -2.80% Retail/Wholesale -0.64% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback